Lasa Supergenerics moves up on joining hand with ICT

17 Mar 2020 Evaluate

Lasa Supergenerics is currently trading at Rs. 40.80, up by 1.90 points or 4.88% from its previous closing of Rs. 38.90 on the BSE.

The scrip opened at Rs. 40.80 and has touched a high and low of Rs. 40.80 and Rs. 40.00 respectively. So far 13741 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 49.70 on 03-Mar-2020 and a 52 week low of Rs. 9.48 on 06-Aug-2019.

Last one week high and low of the scrip stood at Rs. 40.80 and Rs. 34.30 respectively. The current market cap of the company is Rs. 165.94 crore.

The promoters holding in the company stood at 36.80%, while Institutions and Non-Institutions held 0.03% and 63.17% respectively.

Lasa Supergenerics has joined hand with Institute of Chemical Technology (ICT) to develop Favipiravir for treatment of COVID19 which has currently emerged as pandemic.

Favipiravir is an antiviral drug and is a promising antidote for the treatment of Coronavirus disease (COVID-2019). It possesses activity against many RNA viruses. It is a guanine analogue approved for influenza treatment. It can effectively inhibit the RNA-dependent RNA polymerase of RNA viruses such as influenza, Ebola, yellow fever, chikungunya, norovirus and enterovirus, and a recent study reported its activity against 2019-nCoV.

Lasa Supergenerics is pioneer and amongst the leading players in the manufacturing of APIs in India through its catalyst chemistry expertise and fully backward integrated unit.

Lasa Supergenerics Share Price

9.90 -0.10 (-1.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×